Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8768977 | 1.00 | PARP1 (0.32) | PARP1POLBMAPTPGRALDH1A1 | |
| SCHEMBL8767917 | 0.89 | — | — | |
| SCHEMBL8653835 | 0.83 | MAPT (0.46) | POLBMAPTPGRCYP3A4CYP2C19 | |
| SCHEMBL8768992 | 0.82 | PGR (0.32) | PARP1PGR | |
| SCHEMBL8769024 | 0.79 | PGR (0.30) | POLBMAPTPGR | |
| SCHEMBL8407252 | 0.79 | PGR (0.37) | PARP1POLBMAPTPGR | |
| SCHEMBL9173750 | 0.78 | NR3C1 (0.35) | PGR | |
| SCHEMBL8767925 | 0.77 | PGR (0.31) | PARP1PGR | |
| SCHEMBL8768825 | 0.77 | — | — | |
| SCHEMBL8768994 | 0.76 | HSD17B1 (0.33) | PARP1POLBMAPTALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0567469-B1 | 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES | SCHERING AG (DE) | 1997-08-27 | — | — | EP | disclosed |
| US-5426102-A | Antigestagenic, antiandrogenic, antiglucocorticoid, antimineralcorticoid properties | SCHERING AKTIENGESELLSCHAFT (DE) | 1995-06-20 | — | — | US | disclosed |